Submitted by Anonymous (not verified) on 23 July 2025 - 16:25
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 24, Status: Authorised